SK1-I
SK1-I (BML-258), an analog of sphingosine, is an isozyme-specific competitive SPHK1 inhibitor with a Ki value of 10 μM[1]. SK1-I shows no activity at SPHK1 PKCα, PKCδ, PKA, AKT1, ERK1, EGFR, CDK2, IKKβ or CamK2β. SK1-I enhances autophagy and has antitumor activity[2].
Product Specifications
CAS Number
1072443-89-0
Product Name Alternative
BML-258
UNSPSC
12352005
Target
CaMK; SphK
Type
Reference compound
Related Pathways
Immunology/Inflammation; Neuronal Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sk1-i.html
Purity
98.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
OC[C@H]([C@H](/C=C/C1=CC=C(C=C1)CCCCC)O)NC
Molecular Formula
C17H27NO2
Molecular Weight
277.40
References & Citations
[1]Melissa R Pitman, et al. Inhibitors of the sphingosine kinase pathway as potential therapeutics. Curr Cancer Drug Targets. 2010 Jun;10 (4) :354-67.|[2]Santiago Lima, et al. TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition. Autophagy. 2018;14 (6) :942-957.|[3]Fiona H Greig, et al. Requirement for sphingosine kinase 1 in mediating phase 1 of the hypotensive response to anandamide in the anaesthetised mouse. Eur J Pharmacol. 2019 Jan 5;842:1-9.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
SphK1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
32668114 3x 1.0 µg
Olfr1208 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse)
Sign In for Pricing
View Details 
MBS1318939-01 0.02 mg (E-Coli)
Recombinant Human Serine/threonine-protein kinase SIK3 (SIK3) , partial
Sign In for Pricing
View Details MBS1318939-02 0.1 mg (E-Coli)
Recombinant Human Serine/threonine-protein kinase SIK3 (SIK3) , partial
Sign In for Pricing
View Details